These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 31991800)

  • 1. Zebrafish Avatars towards Personalized Medicine-A Comparative Review between Avatar Models.
    Costa B; Estrada MF; Mendes RV; Fior R
    Cells; 2020 Jan; 9(2):. PubMed ID: 31991800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zebrafish patient avatars in cancer biology and precision cancer therapy.
    Fazio M; Ablain J; Chuan Y; Langenau DM; Zon LI
    Nat Rev Cancer; 2020 May; 20(5):263-273. PubMed ID: 32251397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One mouse, one patient paradigm: New avatars of personalized cancer therapy.
    Malaney P; Nicosia SV; Davé V
    Cancer Lett; 2014 Mar; 344(1):1-12. PubMed ID: 24157811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developments in zebrafish avatars as radiotherapy sensitivity reporters - towards personalized medicine.
    Costa B; Ferreira S; Póvoa V; Cardoso MJ; Vieira S; Stroom J; Fidalgo P; Rio-Tinto R; Figueiredo N; Parés O; Greco C; Ferreira MG; Fior R
    EBioMedicine; 2020 Jan; 51():102578. PubMed ID: 31862441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical models as patients' avatars for precision medicine in colorectal cancer: past and future challenges.
    Durinikova E; Buzo K; Arena S
    J Exp Clin Cancer Res; 2021 Jun; 40(1):185. PubMed ID: 34090508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zebrafish Patient-Derived Avatars from Digestive Cancers for Anti-cancer Therapy Screening.
    Costa B; Estrada MF; Barroso MT; Fior R
    Curr Protoc; 2022 Apr; 2(4):e415. PubMed ID: 35436037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zebrafish Avatar to Develop Precision Breast Cancer Therapies.
    Corsinovi D; Usai A; Sarlo M; Giannaccini M; Ori M
    Anticancer Agents Med Chem; 2022; 22(4):748-759. PubMed ID: 33797388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zebrafish Cancer Avatars: A Translational Platform for Analyzing Tumor Heterogeneity and Predicting Patient Outcomes.
    Al-Hamaly MA; Turner LT; Rivera-Martinez A; Rodriguez A; Blackburn JS
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of patient-derived tumor xenograft models and tumor organoids.
    Yoshida GJ
    J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zebrafish Xenografts for Drug Discovery and Personalized Medicine.
    Xiao J; Glasgow E; Agarwal S
    Trends Cancer; 2020 Jul; 6(7):569-579. PubMed ID: 32312681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cancer cell transplantation in zebrafish: From translational research to personalized medicine].
    Raby L; Völkel P; Le Bourhis X; Angrand PO
    Bull Cancer; 2020 Jan; 107(1):30-40. PubMed ID: 31466696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
    Praharaj PP; Bhutia SK; Nagrath S; Bitting RL; Deep G
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):117-127. PubMed ID: 29360544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What role could organoids play in the personalization of cancer treatment?
    Francies HE; Garnett MJ
    Pharmacogenomics; 2015; 16(14):1523-6. PubMed ID: 26485224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organoid technology in cancer precision medicine.
    Xia X; Li F; He J; Aji R; Gao D
    Cancer Lett; 2019 Aug; 457():20-27. PubMed ID: 31078736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and clinical implementations of ovarian cancer mouse avatar models.
    Zayed AA; Mandrekar SJ; Haluska P
    Chin Clin Oncol; 2015 Sep; 4(3):30. PubMed ID: 26408297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Cancer Organoid Model for Drug Screening and Personalized Therapy.
    Kondo J; Inoue M
    Cells; 2019 May; 8(5):. PubMed ID: 31108870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-derived xenograft (PDX) models, applications and challenges in cancer research.
    Abdolahi S; Ghazvinian Z; Muhammadnejad S; Saleh M; Asadzadeh Aghdaei H; Baghaei K
    J Transl Med; 2022 May; 20(1):206. PubMed ID: 35538576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized
    Pauli C; Hopkins BD; Prandi D; Shaw R; Fedrizzi T; Sboner A; Sailer V; Augello M; Puca L; Rosati R; McNary TJ; Churakova Y; Cheung C; Triscott J; Pisapia D; Rao R; Mosquera JM; Robinson B; Faltas BM; Emerling BE; Gadi VK; Bernard B; Elemento O; Beltran H; Demichelis F; Kemp CJ; Grandori C; Cantley LC; Rubin MA
    Cancer Discov; 2017 May; 7(5):462-477. PubMed ID: 28331002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of patient-derived tumor xenografts in cancer treatment.
    Sia D; Moeini A; Labgaa I; Villanueva A
    Pharmacogenomics; 2015; 16(14):1671-83. PubMed ID: 26402657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor organoids: Opportunities and challenges to guide precision medicine.
    Veninga V; Voest EE
    Cancer Cell; 2021 Sep; 39(9):1190-1201. PubMed ID: 34416168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.